"We strive to support our customers in developing more and better biopharmaceuticals to treat patients. By continually innovating to create unique and unrivalled technologies, we bring practical solutions to the problems of the drug discovery and development process"
We provide solutions for customers working across cell line development:
VIEW OUR WEBINAR
"How a Top-5 Pharma Doubled the Speed of Cell Line Development"
Ian Taylor will share his expertise on purchasing the right platform solution at SLAS 2020 Solentim, a global leader in cell line development instrumentation, is pleased to announce it will
19th November 2019: Early last month saw publication of the latest perspectives from the FDA in a paper entitled: Considering “clonality”: A regulatory perspective on the importance of the clonal
What is clonality and why is it important Clonality is a crucial step in stable cell line development (CLD) for biotherapeutic workflows and one closely monitored by the medicines’ regulators.
Insights from the Oxford Global Cell Series UK Conference on the ongoing innovation driving new requirements for cell lines Author: Ian Taylor, Chief Commercial Officer, Solentim At last week’s Oxford
Eliminating enrichment steps in cell line development – reduce cell screening from 5000 to 200 clones per project
Coffee Morning Chat with Ferenc Boldog (ATUM) and Ian Taylor (Solentim): An expert discussion on the evolution of cell line development to negate the need for enrichment In the time
Bournemouth, UK, 8th October 2019: Solentim, the global leader in cell line development instrumentation, is delighted to announce that Mark Stockdale is starting at Solentim in a brand-new role as
Dr Mark Truesdale Solentim, the global leader in cell line development (CLD) instrumentation, is delighted to announce that Dr Mark Truesdale will join the Company as
Dr Andy Tsun, Co-Founder & VP of Discovery Biology at Biotheus Inc China has experienced rapid economic growth over the last ten years. Thanks to economic
GSK presentation on the VIPS system at the forthcoming 8th Annual Cell Culture & Bioprocessing Congress in London re-enforces Solentim’s long-term vision and leadership in cell line development
Solentim is excited to be attending and exhibiting at Oxford Global’s 8th Annual Cell Culture & Bioprocessing Congress, taking place 29-30 October in London. GSK, a valued customer of Solentim,
Solentim to present with Celonic at Biotech Week Boston: new-look VIPS will also premiere at the trade booth
Solentim, a global leader in cell line development instrumentation, is pleased to announce it will be attending and exhibiting at Biotech Week Boston, taking place 9-12 September. Camille Evenou, Scientist